Search research articles
Contact Us
Filters
Showing results (181-190 of 212) with videos related to
Page
of 22
Sort By:
Gut
|
October 23, 2003
Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C
T Asselah, N Boyer, M-C Guimont, et al.
Journal of Viral Hepatitis
|
October 10, 2012
Optimized threshold for serum HCV RNA to predict treatment outcomes in hepatitis C patients receiving peginterferon alfa-2a/ribavirin
S Zeuzem, M Rodríguez-Torres, K Rajender Reddy, et al.
Journal of Viral Hepatitis
|
March 6, 2002
Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis
Manuela G Neuman, J P Benhamou, I M Malkiewicz, et al.
Hepatology (Baltimore, Md.)
|
April 16, 1998
Re-treatment with interferon alfa of patients with chronic hepatitis C
W C Chow, N Boyer, M Pouteau, et al.
Journal of Viral Hepatitis
|
October 15, 2013
IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients
Q Zhang, M Lapalus, T Asselah, et al.
Ugeskrift for Laeger
|
October 15, 1998
[Pretreatment with prednisolone enhances the effect of human lymphoblastoid interferon in chronic hepatitis B]
K Krogsgaard, P Marcellin, C Trepo, et al.
Journal of Hepatology
|
December 1, 1996
Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group
K Krogsgaard, P Marcellin, C Trepo, et al.
Journal of Viral Hepatitis
|
March 13, 2012
Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis C
M Sasso, I Tengher-Barna, M Ziol, et al.
Alimentary Pharmacology & Therapeutics
|
March 28, 2008
Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B
S G Lim, N Leung, H W L Hann, et al.
Journal of Viral Hepatitis
|
June 20, 2007
Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection
D Roulot, V Bourcier, V Grando, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 212) with videos related to
Sort By:
Page
of 22
Gut
|
October 23, 2003
Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C
T Asselah, N Boyer, M-C Guimont, et al.
Journal of Viral Hepatitis
|
October 10, 2012
Optimized threshold for serum HCV RNA to predict treatment outcomes in hepatitis C patients receiving peginterferon alfa-2a/ribavirin
S Zeuzem, M Rodríguez-Torres, K Rajender Reddy, et al.
Journal of Viral Hepatitis
|
March 6, 2002
Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis
Manuela G Neuman, J P Benhamou, I M Malkiewicz, et al.
Hepatology (Baltimore, Md.)
|
April 16, 1998
Re-treatment with interferon alfa of patients with chronic hepatitis C
W C Chow, N Boyer, M Pouteau, et al.
Journal of Viral Hepatitis
|
October 15, 2013
IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients
Q Zhang, M Lapalus, T Asselah, et al.
Ugeskrift for Laeger
|
October 15, 1998
[Pretreatment with prednisolone enhances the effect of human lymphoblastoid interferon in chronic hepatitis B]
K Krogsgaard, P Marcellin, C Trepo, et al.
Journal of Hepatology
|
December 1, 1996
Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group
K Krogsgaard, P Marcellin, C Trepo, et al.
Journal of Viral Hepatitis
|
March 13, 2012
Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis C
M Sasso, I Tengher-Barna, M Ziol, et al.
Alimentary Pharmacology & Therapeutics
|
March 28, 2008
Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B
S G Lim, N Leung, H W L Hann, et al.
Journal of Viral Hepatitis
|
June 20, 2007
Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection
D Roulot, V Bourcier, V Grando, et al.
Page
of 22